Table 2 Multivariate analysis for PFS in 64 nasopharyngeal carcinoma patients with SARS-CoV-2 infection
Characteristics | PFS | |
|---|---|---|
HR (95% CI) | P | |
Age (< 50 vs. ≥ 50 years) | 2.87 (0.70–11.79) | 0.144 |
Sex (male vs. female) | 0.48 (0.10–2.27) | 0.355 |
T stage (T1–2 vs. T3–4) | 1.04 (0.19–5.68) | 0.969 |
N stage (N0–1 vs. N2–3) | 0.59 (0.14–2.44) | 0.467 |
TNM stage (1–2 vs. 3–4) | 3.23 (0.19–54.70) | 0.418 |
Symptoms of COVID-19 (No vs. Yes) | – | 0.979 |
Fever (No vs. Yes) | 0.80 (0.20–3.31) | 0.762 |